Investors

Key press releases

Key upcoming events

Key corporate presentation

Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).

Cellectis ADS (Nasdaq)

Ticker: CLLS

$2.4200

-0.0600 (-2.4194%)

Prev. close
2.4800
Volume
89,986
High
2.4800
Capitalization
173.638M
Last Update: 7 hours ago

Cellectis (Euronext Growth Paris)

Ticker: ALCLS

€2.1750

-0.0700 (-3.1180%)

Prev. close
2.2450
Volume
83,895
High
2.2400
Capitalization
156.059M
Last Update: about 12 hours ago

Covering research analysts

Barclays - Gena Wang

Bryan Garnier - Alex Cogut 

Citi - Yigal Nochomovitz

Goldman Sachs - Salveen Richter

Jefferies - Kelly Shi

JMP Securities - Silvan Tuerkcan

Jones Trading - Soumit Roy

Kempen -  Sebastiaan van der Schoot

Oddo BHF - Martial Descoutures

Oppenheimer – Hartaj Singh

RW Baird - Jack Allen

Wells Fargo – Yanan Zhu

Cellectis contact information

Arthur Stril, Chief Business Officer

Ashley R. Robinson, LifeSci Advisors

Citibank ADR contact information

Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030

Société Générale Securities Services - Ordinary Shares contact information

Call center in English and French

Monday to Friday from 8:30am to 6pm CEST

+33 (0)2 51 85 67 89